Philips and BG Medicine partner in molecular medicine for early detection and monitoring of diseases
Philips announced that it has reached a development partnership agreement with BG medicine. Under the agreement Philips Research will collaborate with BG Medicine to advance Philips' development of patient-centered diagnostics and personalized medicine. As a further part of this strategic agreement Philips will take a minority stake in BG Medicine.
The Philips-BG Medicine partnership is an extension of Philips' existing molecular medicine research and development efforts. The collaboration gives Philips access to certain BG Medicine proprietary biomarker discovery and validation technologies, and associated services.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.